Lifespan Edge, a longevity clinic co-founded by futurist John Mauldin and preventive medicine pioneer Dr. Michael Roizen, has announced the opening of two new locations in West Palm Beach, Florida, and Columbia, Maryland, with a third planned for Scottsdale, Arizona. This expansion underscores the company's mission to make personalized, evidence-based longevity care more accessible to individuals seeking to optimize healthspan, cognitive vitality, and quality of life.
Founded in 2024, Lifespan Edge aims to bridge cutting-edge longevity research with individualized clinical care. Dr. Michael Roizen, Chair of the Board and Co-Founder, emphasized that healthcare should begin decades before disease appears. “Many of the factors influencing how we age are modifiable,” he said. “Through personalized care, informed lifestyle choices, and emerging scientific advances, individuals can take greater control of their long-term health.”
The new locations are at 2528 Okeechobee Blvd., West Palm Beach, FL 33409, and 10700 Charter Drive, Suite 200, Columbia, MD 21044. The Scottsdale site will be a premier luxury wellness destination serving clients nationwide and abroad. Each clinic offers a concierge-style experience combining advanced diagnostics, physician-guided evaluations, and personalized strategies focused on prevention, performance, and healthy aging.
Interest in longevity medicine has accelerated as consumers seek proactive approaches to maintaining cognitive function, metabolic health, and physical resilience. Lifespan Edge emphasizes identifying risk factors early and creating individualized plans for long-term wellness, rather than treating disease after symptoms arise. John Mauldin, President and Co-Founder, believes this represents a fundamental evolution in healthcare. “We saw an opportunity to bring together leading physicians, science-driven medicine, and personalized care under one roof,” he said. “As longevity research advances, we want our clinics to translate that science into practical strategies that empower people to live healthier, more productive lives.”
One area of growing scientific interest is Therapeutic Plasma Exchange (TPE), a medical procedure being investigated for potential applications in aging and neurodegenerative disease. Notable research includes the AMBAR (Alzheimer Management by Albumin Replacement) clinical trial, which evaluated plasma exchange with albumin replacement in patients with mild-to-moderate Alzheimer’s disease. Published findings reported the intervention showed promise in slowing decline in certain cognitive and functional measures, though investigators emphasized that additional research is needed to define its role and long-term impact.
Dr. Roizen noted that the most exciting developments in longevity are helping us understand how the body repairs itself and how interventions may support healthier aging. “Our philosophy is to follow the science, personalize care, and continually evaluate new evidence as it emerges,” he said. He has long advocated that biological age and chronological age are not always the same, and that lifestyle choices—nutrition, physical activity, stress management, purpose, and social connection—can meaningfully influence long-term health.
With additional locations planned, Lifespan Edge aims to help redefine aging by bringing together physician expertise, advanced diagnostics, and evolving longevity science. The expansion into Florida, Maryland, and soon Arizona represents an important step toward making sophisticated longevity care available to more communities across the country. Co-Founder Dr. Michael Roizen was recently featured in Entrepreneur and TopDoctor Magazine, where he shared his philosophy that persistence, prevention, and personalized care can reshape healthcare and redefine aging.
